Lead Plaintiff Deadline: December 13, 2021
Please Upload related files below
Fill in below.
Looking for more?
pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s March 2021 initial public offering.
(1) certain of InnovAge’s facilities failed to provide covered services, provide accessible and adequate services, manage participants’ medical situations, and oversee use of specialists; (2) as a result, the Company was reasonably likely to be subject to regulatory scrutiny, including by the Centers for Medicare and Medicaid Services; (3) as a result, there as a significant risk that CMS would suspend new enrollments pending an audit of the Company’s services; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
In order to be included in the lawsuit, you must have incurred a loss on shares of InnovAge, either: A) purchased or acquired during the class period listed above, if applicable; or B) pursuant to the Initial Public Offering (IPO) of InnovAge, if applicable.
If you suffered a loss in InnovAge during the relevant time frame, or pursuant to InnovAge’s IPO if listed above, you have until December 13, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.